Thrombosis in three postmenopausal women receiving testosterone therapy for low libido

Women's Health

Volumn 9, Issue 4, 2013, Pages 405-410

  Glueck, Charles J ^a   Bowe, Dedrick ^a   Valdez, Alejandro ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

Central retinal vein thrombosis; G20210A prothrombin gene mutation; Hyperhomocysteinemia; Osteonecrosis; Testosterone; Testosterone estradiol; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; TESTOSTERONE; THROMBOPLASTIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BONE NECROSIS; CASE REPORT; CENTRAL RETINAL VEIN OCCLUSION THROMBOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; GENE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; LIBIDO DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OVARIECTOMY; PAI 1 GENE; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; TESTOSTERONE BLOOD LEVEL; VEIN THROMBOSIS; X RAY;

ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HIP JOINT; HUMANS; LIBIDO; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OSTEONECROSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTMENOPAUSE; PROTHROMBIN; RETINAL VEIN OCCLUSION; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; THROMBOSIS;

EID: 84880358130     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.13.31     Document Type: Article

References (39)

1. Glueck CJ, Goldenberg N, Budhani S et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl. Res. 158, 225-234 (2011).
2. Glueck CJ, Freiberg RA, Wang P. Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head. Clin. Orthop. Relat. Res. 466, 1034-1040 (2008).
3. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 5, 98-102 (2002).
4. Cherrier MM, Matsumoto AM, Amory JK et al. The role of aromatization in testosterone supplementation: Effects on cognition in older men. Neurology 64, 290-296 (2005).
5. Jankowska EA, Rozentryt P, Ponikowska B et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA 301, 1892-1901 (2009).
6. Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CP. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am. J. Physiol. Endocrinol. Metab. 291, E631-E638 (2006). (Pubitemid 44352271)
7. Roldan V, Lecumberri R, Munoz-Torrero JF et al. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb. Res. 124, 174-177 (2009).
8. Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P. Thrombophilia and retinal vascular occlusion. Clin. Ophthalmol. 6, 1377-1384 (2012).
9. Davis PH. Use of oral contraceptives and postmenopausal hormone replacement: Evidence on risk of stroke. Curr. Treat. Options Neurol. 10, 468-474 (2008).
10. Glueck CJ, Richardson-Royer C, Schultz R et al. Testosterone, thrombophilia, and thrombosis. Clin. Appl. Thromb. Hemost. doi:10.1177/ 1076029613485154 (2013) (Epub ahead of print).
11. Derman RJ. Effects of sex steroids on women's health: Implications for practitioners. Am. J. Med. 98, S137-S143 (1995).
12. Bancroft J, Graham CA. The varied nature of women's sexuality: Unresolved issues and a theoretical approach. Horm. Behav. 59, 717-729 (2011).
13. Davey DA. Androgens in women before and after the menopause and post bilateral oophorectomy: Clinical effects and indications for testosterone therapy. Womens Health (Lond. Engl.) 8, 437-446 (2012).
14. Braunstein GD, Sundwall DA, Katz M et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch. Intern. Med. 165, 1582-1589 (2005). (Pubitemid 41124151)
15. Buster JE, Kingsberg SA, Aguirre O et al. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet. Gynecol. 105, 944-952 (2005). (Pubitemid 40571010)
16. Simon J, Braunstein G, Nachtigall L et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. 90, 5226-5233 (2005). (Pubitemid 41262278)
17. Alexander JL, Dennerstein L, Burger H, Graziottin A. Testosterone and libido in surgically and naturally menopausal women. Womens Health (Lond. Engl.) 2, 459-477 (2006).
18. Shifren JL, Davis SR, Moreau M et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 13, 770-779 (2006).
19. Glueck CJ, Richardson-Royer C, Schultz R et al. Testosterone, thrombophilia, thrombosis. Clin. Acquired Thromb. Hemost. doi:10.1177/ 1076029613485154 (2013) (Epub ahead of print).
20. Balasa VV, Gruppo RA, Glueck CJ et al. Legg-Calve-Perthes disease and thrombophilia. J. Bone Joint Surg. Am. 86-A, 2642-2647 (2004).
21. Balasa VV, Gruppo RA, Glueck CJ et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb. Haemost. 81, 739-744 (1999). (Pubitemid 29216560)
22. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin. Appl. Thromb. Hemost. 11, 375-389 (2005). (Pubitemid 41546764)
23. Glueck CJ, Pranikoff J, Aregawi D et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: Etiologies for sporadic miscarriage. Metabolism 54, 1345-1349 (2005). (Pubitemid 41262592)
24. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and d-dimer. Metabolism 42, 236-246 (1993). (Pubitemid 23051468)
25. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin. Orthop. Relat. Res. 19-33 (2001). (Pubitemid 32391273)
26. Bjorkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Arch. Orthop. Trauma Surg. 125, 51-55 (2005). (Pubitemid 40305469)
27. Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J. Bone Joint Surg. Am. 90, 2220-2229 (2008).
28. Glueck CJ, Freiberg RA, Boriel G et al. The role of the factor V leiden mutation in osteonecrosis of the hip. Clin. Appl. Thromb. Hemost. doi:10.1177/1076029612449901 (2012) (Epub ahead of print).
29. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277, 1305-1307 (1997). (Pubitemid 27194355)
30. Middeldorp S. Is thrombophilia testing useful? Hematol. Am. Soc. Hematol. Educ. Program 2011, 150-155 (2011).
31. Kvasnicka J, Hajkova J, Bobcikova P et al. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)]. Cas. Lek. Cesk. 151, 76-82 (2012).
32. Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. N. Engl. J. Med. 363, 109-122 (2010).
33. Kenemans P, Van Der Mooren MJ. Androgens and breast cancer risk. Gynecol. Endocrinol. 28(Suppl. 1), S46-S49 (2012).
34. Glaser R, Kalantaridou S, Dimitrakakis C. Testosterone implants in women: Pharmacological dosing for a physiologic effect. Maturitas 74, 179-184 (2013).
35. Svartberg J, Braekkan SK, Laughlin GA, Hansen JB. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: The Tromso study. Eur. J. Endocrinol. 160, 833-838 (2009).
36. Wramsby ML, Bokarewa MI, Blomback M, Bremme AK. Response to activated protein C during normal menstrual cycle and ovarian stimulation. Hum. Reprod. 15, 795-797 (2000). (Pubitemid 30192725)
37. Liljeqvist S, Hellden A, Bergman U, Soderberg M. Pulmonary embolism associated with the use of anabolic steroids. Eur. J. Intern. Med. 19, 214-215 (2008). (Pubitemid 351459624)
38. Sahraian MA, Mottamedi M, Azimi AR, Moghimi B. Androgen-induced cerebral venous sinus thrombosis in a young body builder: Case report. BMC Neurol. 4(1), 22 (2004).
39. Schover LR. Androgen therapy for loss of desire in women: Is the benefit worth the breast cancer risk? Fertil. Steril. 90, 129-140 (2008). (Pubitemid 351888358)